课题基金 / 基金详情

新規DNA相同組み換え機構に基づく細胞選択的合成致死誘導の開発

新規DNA相同組み換え機構に基づく細胞選択的合成致死誘導の開発
基于新型DNA同源重组机制的细胞选择性合成致死诱导的发展
批准号:
20K08071
负责人:
田嶋 克史
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
人RAD52蛋白参与DNA双链断裂(DSB)位点的单链退火(SSA)和同源重组(HR)修复,并且它也是BRCA 2缺陷细胞中细胞生长所必需的。对RAD 52的结构和生物化学分析已经鉴定了几个DNA结合位点,如在RAD 52环的沟中的赖氨酸(K)和精氨酸(R)氨基酸残基。然而,目前尚不清楚RAD52上的哪些氨基酸分别参与与BRCA2相关的HR、SSA和细胞生长。K和R的丙氨酸(A)取代揭示了RAD 52上的K102、K152和R153 DNA结合位点对于SSA和HR都是必需的,而K133仅参与SSA修复。在102(K102A)处的K至丙氨酸(A)的取代恶化,不是正常的细胞生长,而是仅BRCA 2缺陷的细胞生长。K133可能参与HR和SSA修复之间的通路选择。本研究为RDA52功能及其应用提供了有见地的分子特性。
英文摘要
Human RAD52 protein participates in single-strand annealing (SSA) and homologous recombinational (HR) repair at DNA double-strand break (DSB) sites, and it is also required for cell growth in BRCA2-deficient cells. Structural and biochemical analyses of RAD52 have identified several DNA-binding sites as lysine (K) and arginine (R) amino acid residues, in the groove of RAD52 ring. However, it is unclear which amino acids on RAD52 are involved in HR, SSA, and cell growth associated with BRCA2, respectively. Alanine (A) substitution of K and R revealed that K102, K152, and R153 DNA binding sites on RAD52 were essential for both SSA and HR, whereas K133 was only involved in SSA repair. K to alanine(A) substitution at 102 (K102A) deteriorated, not normal cell growth but only BRCA2-deficient cell growth. K133 might be involved in the pathway choice between HR and SSA repair. The present study provides insightful molecular properties for RDA52 functions and its applications.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin
使用利妥昔单抗和 brentuximab vedotin 治疗的具有 T 辅助表型的复合弥漫性大 B 细胞和外周 T 细胞淋巴瘤
DOI: 10.1007/s00277-021-04633-6
发表时间: 2021
期刊: Annals of Hematology
影响因子: 3.5
作者: [Ohya Kouichi, Okuyama Shuhei, Ogata Shin-ya, Maeda Kunihiko, Yamada Kyohei, Ohshima Kouichi, Tajima Katsushi]
通讯作者: Tajima Katsushi
DOI: 10.1080/10428194.2022.2038379
发表时间: 2022
期刊: Leukemia & Lymphoma
影响因子: 2.6
作者: [Tajima Katsushi, Tanaka Kiwa, Takeda Hikaru, Moriya Mika, Ueki Tetsuya, Ogata Shinya, Maeda Kunihiko, Yasuda Takeshi]
通讯作者: Yasuda Takeshi
DOI: 10.1007/s00432-020-03279-7
发表时间: 2020-06
期刊: Journal of Cancer Research and Clinical Oncology
影响因子: 3.6
作者: [Masakazu Yamamoto;Ikuko Suzuki;K. Saitou;Riko Tsumanuma;Shuhei Okuyama;Hiroaki Kumagai;E. Omoto;S. Satoh;K. Tajima]
通讯作者: Masakazu Yamamoto;Ikuko Suzuki;K. Saitou;Riko Tsumanuma;Shuhei Okuyama;Hiroaki Kumagai;E. Omoto;S. Satoh;K. Tajima
Solitary follicular lymphoma with plasmacytic differentiation associated with localized AL amyloidosis in the jejunum
孤立性滤泡性淋巴瘤伴浆细胞分化,与空肠局部 AL 淀粉样变性相关
DOI: 10.1007/s00277-023-05207-4
发表时间: 2023
期刊: Annals of Hematology
影响因子: 3.5
作者: [Tajima Katsushi, Nomura Takashi, Terada Taichi, Okuyama Shuhei, Kumagai Hiroaki, Maeda Kunihiko, Ogata Shinya, Naiki Hironobu]
通讯作者: Naiki Hironobu
海外基金